Source comparison
Melanotan 2 vs. Approved Alternatives: A Clear Comparison
To put the legal and safety differences in stark relief, it’s helpful to compare MT2 to a compound that successfully navigated the FDA approval process. Bremelanotide (sold as Vyleesi) is a perfect example, as it's a direct descendant of Melanotan 2 research.
This comparison does not assign a generated winner or score.
- To put the legal and safety differences in stark relief, it’s helpful to compare MT2 to a compound that successfully navigated the FDA approval process. Bremelanotide (sold as Vyleesi) is a perfect example, as it's a direct descendant of Melanotan 2 research.
- Legal Status (US)
- Unapproved by FDA. Legal for research only.
- FDA-approved prescription drug.
- Primary Indication
- None (Investigational for tanning/libido).
- Treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women.
- Mechanism
- Binds to multiple melanocortin receptors (MC1R, MC3R, MC4R, MC5R).
- More selective, primarily targeting MC3R and MC4R, with less effect on MC1R.
- Known Side Effects
- Nausea, flushing, tanning, blood pressure changes, potential melanoma risk.
- Nausea, flushing, headache, injection site reactions. Tanning effect is minimal.
- Regulation & QC
- Unregulated market. Purity and safety vary wildly.
- Manufactured under strict cGMP standards. Consistent dosage and purity.
- Availability
- Sold by research chemical suppliers.
- Requires a prescription from a licensed healthcare provider.
- This table makes the distinction crystal clear. One is a regulated pharmaceutical with a specific, approved use and a known safety profile. The other is an unregulated chemical with unknown long-term risks, confined to laboratory settings for a reason. Our research-grade PT-141 Bremelanotide is available for scientists studying these mechanisms, but it exists in a completely different legal universe from its FDA-approved counterpart.